Today's Low
₹ 52.50
Today's High
₹ 54.50
52 Weeks Low
₹ 30.20
52 Weeks High
₹ 48.45
Lower
₹ 51.25
Upper
₹ 56.60
N.K Industries Limited manufactures, sells, and trades in castor oil and its derivatives in India. Its products include commercial grade castor oil, cold pressed castor oil, castor oil British Pharma 93 grade, first pressed degummed castor oil, pale pressed grade grade castor oil, sodium sulphate anhydrous, refined castor oil, crude glycerin, de oiled cakes-castor meals, 12-hydroxy stearic acid flakes/powder, ricinoleic acid, hydrogenated castor oil, and high protein castor meal. N.K Industries Limited was incorporated in 1987 and is based in Ahmedabad, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 25.1 | 24.6 | 24.8 | 25.7 | 67.1 | 49.1 | 43.8 | 41.2 | 53.8 |
Total Non-Current Assets | 1,848.6 | 1,851.4 | 1,854.0 | 1,855.6 | 1,865.2 | 1,792.6 | 270.3 | 279.5 | 305.1 |
Total Assets | 1,873.7 | 1,876.0 | 1,878.8 | 1,881.3 | 1,932.3 | 1,841.7 | 314.1 | 320.7 | 358.9 |
Total Current Liabilities | 4.0 | 4.0 | 4.9 | 4.6 | 50.5 | 7.4 | 4.4 | 3.2 | 40.7 |
Total Non-Current Liabilities | 2,212.5 | 2,213.1 | 2,213.6 | 2,213.9 | 2,212.5 | 2,146.3 | 618.4 | 633.5 | 629.9 |
Shareholder's Funds | -342.9 | -341.1 | -339.7 | -337.2 | -330.7 | -312.1 | -308.7 | -316.0 | -311.7 |
Total Liabilities | 1,873.7 | 1,876.0 | 1,878.8 | 1,881.3 | 1,932.3 | 1,841.7 | 314.1 | 320.7 | 358.9 |
The Industry Quick Ratio stands at 0.58, vs the Quick Ratio of 5.04, which results in a Positive aspect.
The Industry Price to BV stands at 5.02, vs the Price to BV of -0.07, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.59, vs the Debt to Equity Ratio of 0.00, which results in a Positive aspect.
The Industry Current Ratio stands at 1.21, vs the Current Ratio of 5.62, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
---|---|---|---|---|---|---|---|---|---|
Total Income | 17.8 | 20.3 | 22.0 | 114.9 | 515.4 | 134.1 | 108.1 | 104.4 | 67.1 |
Total Expenditure | 16.5 | 18.2 | 20.3 | 115.1 | 539.7 | 127.0 | 103.7 | 97.7 | 68.3 |
Operating Profit(Excl OI) | 1.7 | 2.6 | 2.2 | 0.9 | -19.9 | 8.0 | 6.3 | 7.4 | -0.3 |
Add: Other Income | 0.4 | 0.4 | 0.5 | 1.1 | 4.4 | 0.9 | 1.9 | 0.7 | 0.9 |
Operating Profit | 1.7 | 2.6 | 2.2 | 0.9 | -19.9 | 8.0 | 6.3 | 7.4 | -0.3 |
Less: Interest | 0.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 |
PBDT | 1.3 | 2.6 | 2.2 | 0.9 | -19.9 | 7.9 | 6.3 | 7.4 | -0.4 |
Less: Depreciation Amortization | 3.7 | 4.6 | 5.1 | 6.0 | 7.1 | 10.2 | 12.6 | 13.3 | 24.2 |
PBT & Exceptional Items | -2.4 | -2.0 | -2.9 | -5.2 | -27.1 | -2.4 | -6.3 | -5.9 | -24.7 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | -2.4 | -2.0 | -2.9 | -5.2 | -27.1 | -2.4 | -6.3 | -5.9 | -24.7 |
Less: Taxation | -0.5 | -0.5 | -0.6 | 1.1 | -8.4 | 0.9 | -1.5 | -1.6 | 0.0 |
Profit After Tax | -1.9 | -1.5 | -2.3 | -6.3 | -18.7 | -3.2 | -4.8 | -4.3 | -24.7 |
Earnings Per Share | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry Dividend Yield stands at 0.04, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PE Ratio stands at 458.61, vs the PE Ratio of 0.00, which results in a Negative aspect.
The Industry PAT Margin stands at 1.47, vs the PAT Margin of -5.46, which results in a Negative aspect.
The Industry PAT Growth stands at 17.52, vs the PAT Growth of 66.38, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | -2.2 | -2.0 | -3.2 | -5.4 | -27.1 | -2.5 | -6.3 | -5.9 | -24.6 |
Tax Paid | 0.0 | -0.1 | 0.0 | -0.1 | -0.5 | -0.2 | -0.1 | -0.1 | 0.0 |
Adjustment | 3.8 | 4.3 | 4.8 | 5.8 | 7.0 | 10.0 | 12.2 | 15.6 | 24.3 |
Changes In Working Capital | -2.2 | -2.0 | -3.2 | -5.4 | -27.1 | -2.5 | -6.3 | -5.9 | -24.6 |
Cash Flow after changes in Working Capital | 0.4 | 1.4 | 3.6 | -9.0 | 14.3 | 5.0 | 4.1 | -21.5 | 3.2 |
Cash Flow from Operating Activities | 0.4 | 1.3 | 3.6 | -9.1 | 13.7 | 4.8 | 4.0 | -21.5 | 3.2 |
Cash Flow from Investing Activities | -0.3 | -1.4 | -3.2 | 3.9 | -8.1 | -1,532.2 | -2.7 | 16.8 | -2.7 |
Cash Flow from Financing Activities | -0.4 | 0.0 | 0.0 | 0.0 | -0.1 | 1,527.4 | -1.4 | 4.5 | -0.1 |
Net Cash Inflow / Outflow | -0.3 | -0.2 | 0.4 | -5.2 | 5.6 | 0.0 | -0.1 | -0.2 | 0.4 |
Opening Cash & Cash Equivalents | 1.8 | 1.9 | 1.5 | 6.8 | 1.1 | 1.1 | 1.2 | 1.4 | 1.0 |
Closing Cash & Cash Equivalent | 1.5 | 1.8 | 1.9 | 1.5 | 6.8 | 1.1 | 1.1 | 1.2 | 1.4 |
The Industry PCF RATIO stands at 31.55, vs the PCF RATIO of -1.38, which results in a Negative aspect.
The Industry PFCF Ratio stands at 25.60, vs the PFCF Ratio of -1.26, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 44.5 | 44.5 | 48.7 | 86.3 | 47.7 | 43.5 | 40.6 | 50.9 | 52.5 | 50.3 | 54.1 | 68.3 | 52.2 | 55.2 | 50.9 | 49.8 |
Total Income | 44.5 | 44.5 | 48.7 | 86.3 | 47.7 | 43.5 | 40.6 | 50.9 | 52.5 | 50.3 | 54.1 | 68.3 | 52.2 | 55.2 | 50.9 | 49.8 |
Total Expenditure | 42.0 | 45.5 | 47.5 | 78.9 | 42.2 | 42.7 | 40.3 | 41.0 | 45.2 | 43.5 | 52.0 | 51.5 | 52.5 | 53.9 | 46.4 | 56.9 |
PBIDT (Excl OI) | 2.5 | -1.0 | 1.2 | 7.3 | 5.5 | 0.8 | 0.4 | 9.9 | 7.4 | 6.8 | 2.1 | 16.8 | -0.3 | 1.3 | 4.5 | -7.1 |
Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Operating Profit | 2.5 | -1.0 | 1.2 | 7.3 | 5.5 | 0.8 | 0.4 | 9.9 | 7.4 | 6.8 | 2.1 | 16.8 | -0.3 | 1.3 | 4.5 | -7.1 |
Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.8 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | -0.5 | 0.2 | 0.2 | 0.2 | -0.4 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 | 1.0 | -1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 2.5 | -1.0 | 1.2 | 8.3 | 5.5 | -2.0 | -0.6 | 9.9 | 6.8 | 6.8 | 2.1 | 17.3 | -0.5 | 1.1 | 4.3 | -6.7 |
Depreciation | 7.7 | 7.9 | 7.8 | 8.7 | 8.5 | 9.9 | 10.2 | 11.4 | 11.5 | 11.5 | 11.4 | 12.3 | 12.9 | 13.0 | 12.8 | 15.6 |
Profit Before Tax | -5.2 | -8.9 | -6.6 | -0.4 | -3.0 | -11.9 | -10.8 | -1.5 | -4.7 | -4.7 | -9.3 | 5.0 | -13.4 | -11.8 | -8.5 | -22.3 |
Tax | -1.1 | -1.0 | 0.2 | -4.2 | -0.9 | -3.1 | -2.3 | 0.1 | -1.0 | -1.5 | -2.5 | -3.2 | 2.9 | -6.8 | 0.9 | -34.7 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | -4.1 | -7.9 | -6.8 | 3.8 | -2.0 | -8.9 | -8.5 | -1.6 | -3.7 | -3.3 | -6.8 | 8.2 | -16.4 | -5.1 | -9.4 | 12.4 |
Net Profit | -4.1 | -7.9 | -6.8 | 3.8 | -2.0 | -8.9 | -8.5 | -1.6 | -3.7 | -3.3 | -6.8 | 8.2 | -16.4 | -5.1 | -9.4 | 12.4 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 | 60.1 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | -0.7 | -1.3 | -1.1 | 0.6 | -0.3 | -1.5 | -1.4 | -0.3 | -0.6 | -0.5 | -1.1 | 1.4 | -2.8 | -0.9 | -1.6 | 1.8 |
Operating Profit Margin | 5.6 | -2.2 | 2.5 | 8.5 | 11.6 | 1.9 | 1.0 | 19.4 | 14.0 | 13.5 | 3.9 | 24.6 | -0.6 | 2.4 | 8.9 | -14.3 |
Net Profit Margin | -9.1 | -17.8 | -13.9 | 4.4 | -4.3 | -20.4 | -20.9 | -3.2 | -7.0 | -6.5 | -12.5 | 12.1 | -31.3 | -9.2 | -18.5 | 24.9 |
The Industry Net Sales Growth stands at 19.70, vs the Net Sales Growth of -77.71, which results in a Negative aspect.
The Industry Mcap Growth stands at 4.81, vs the Mcap Growth of -48.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 53.75 | 54.51 | 52.81 |
R3 | 53.50 | 53.43 | 52.63 |
R2 | 53.25 | 53.21 | 52.57 |
R1 | 52.85 | 52.78 | 52.51 |
Pivot | 52.60 | 52.56 | 52.60 |
S1 | 52.20 | 52.13 | 52.39 |
S2 | 51.95 | 51.91 | 52.33 |
S3 | 51.55 | 51.48 | 52.27 |
S4 | 51.15 | 50.61 | 52.09 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
33.33
Neutral
RSI
38.18
Neutral
ROC
-6.25
Bearish
UltimateOscillator
51.65
Neutral
Williams Indicator
-68.45
Neutral
CCI Indicator
-68.38
Neutral
MACD
-2,884.45
Bearish
Stochastic Indicator
40.64
Neutral
ATR
2.67
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
23-01-2024 | Quarterly Results & Inter alia, to consider and approve :- 1. To take note of resignation of Mr. Divyesh Aswar as Company Secretary and Compliance Officer of the Company. 2. Appointment of Ms. Jelin Dodiya as Company Secretary and Compliance Officer of the Company. 3. Any other business as may be considered fit and proper by the Chair |
09-11-2023 | Quarterly Results |
25-08-2023 | A.G.M. |
07-08-2023 | Quarterly Results |
02-05-2023 | Audited Results |
03-02-2023 | Quarterly Results |
07-11-2022 | Quarterly Results |
24-08-2022 | Inter alia, to consider and approve : 1. To consider convening of Annual General Meeting of the Company and to approve the draft notice thereof. 2. To consider providing of e-voting facility to the shareholders for the ensuing Annual General Meeting and appointment of Scrutinizer for the said purpose. 3. To consider and approve the Board's Report for the year ended on 31st March, 2022 along with its annexures. 4. To determine dates for book closure and cut-off date for e-voting and e-voting period. 5. Any other business as may be considered fit and proper by the Chair. |
02-08-2022 | Quarterly Results |
19-05-2022 | Audited Results |
01-02-2022 | Quarterly Results |
27-10-2021 | Quarterly Results |
31-07-2021 | Quarterly Results & A.G.M. |
07-06-2021 | Audited Results |